Hospira Inc, Lake Forest, Ill, announces that it has acquired the EndoTool business from MD Scientific, LLC.
EndoTool is an FDA-approved glucose management software system that monitors, adjusts, and predicts future dosage levels of IV insults for each individual patient in acute, critical care, and operating room settings.
Hospira also acquired additional assets related to the EndoTool business, including the MD Scientific headquarters in Charlotte, NC, and the employees supporting the product. Endotool is used in many leading health care institutions in both community and academic settings.
The company will demonstrate the EndoTool at the American Nurses’ Credentialing Center (ANCC) National Magnet Conference, Oct 15 through 17, in Salt Lake City.